Clinical Trials in Belgium / NCT06477627
Active, not recruiting
Not applicable
The Coastal Exposome: a Study of Sea Air Inhalation and Possible Links to Health
NCT06477627 · tracked via the Priya Life Science Belgium tracker
Condition(s) studied
Difference Between Coastal and Inland Populations
Investigational drug(s) / intervention(s)
no intervention
no intervention: no intervention, people just indicate if they spend time inland or at the coast
Study summary
The research aims to understand oceans as crucial contributors to human health in coastal environments. Oceans produce marine spray aerosols that contain a mixture of microbiota and natural biological molecules (biogenics).
Eligibility
Inclusion Criteria:
* healthy participants between 18 and 50 years old
Exclusion Criteria:
* people with a medical condition
* people younger than 18 and older than 50
Primary outcome measure(s)
- nose swabs: respiratory microbiome and biogenics profile — 4 times during the 8 week study period
DNA from the nose swabs will be analysed using sequencing for analyzing the microbiome. Biogenics on the swabs will be analysed as well, to get an idea of what molecules and microbiota from the sea air are inhaled. This will happen with UPLC-QTOF-MS. - VAMS blood samples: cytokines — 4 times during the 8 week study period
Cytokines will be measured in blood samples to link the sea air exposure to the human health. A multiplex kit will be used to measure 20 cytokines. - GPS — during the 8 week study period, if more than 15 minutes spend outside
via sensorlogger app on their phone, to collect GPS data when outside. - questionnaires — at the start, in the middle and at the end of the 8 weeks.
Filling in a questionnaire via qualtrics
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Ghent University | Ghent | Oost-Vlaanderen |
More University Ghent trials in Belgium
fNIRS Grasping Task in Infants
Recruiting
Metabotyping of Overweight and Obese Children
Active, not recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06477627 on ClinicalTrials.gov ↗ ← All trials in Belgium